ASH Annual Meeting 2026 is the world’s premier hematology conference, bringing together leading physicians, researchers, scientists, and healthcare professionals to explore the latest advances in blood diseases, hematologic malignancies, and clinical care. Organized by the American Society of Hematology, the meeting is internationally recognized for presenting cutting-edge research, breakthrough clinical trials, and emerging therapies that transform the diagnosis and treatment of blood disorders.

Held in San Diego, California, the conference features world-renowned keynote speakers, scientific sessions, educational workshops, abstract presentations, poster discussions, and one of the largest medical exhibitions dedicated to hematology. Participants gain insights into advances in leukemia, lymphoma, multiple myeloma, bone marrow transplantation, cellular therapies, immunotherapy, coagulation disorders, thrombosis, gene therapy, precision medicine, and innovative diagnostic technologies.

As the flagship event of the global hematology community, the ASH Annual Meeting 2026 promotes scientific excellence, international collaboration, and continuous medical education. The congress offers unparalleled opportunities for networking, professional development, and knowledge exchange among clinicians, researchers, pharmaceutical companies, and healthcare organizations committed to advancing blood disease research and patient care.